DE-108 Ophthalmic Solution

· Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DE-108 Ophthalmic Solution, covering 2017-10-12 to 2017-10-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery [Phase 3]